Skip to content
healthcare.dev

Zemaira

NDC 0053-7201, alpha-1-proteinase inhibitor human, kit, from CSL Behring LLC.

Product NDC
0053-7201
Status
Listed
Labeler
CSL Behring LLC
Dosage form
KIT
Route
—
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125078
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0053-7201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
0053-7201-02000537201021 KIT in 1 CARTON (0053-7201-02) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7211-01) * 20 mL in 1 VIAL, SINGLE-DOSE (0053-7653-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0053-7201

Use it

Look up 0053-7201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0053-7201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0053-7201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.